Abstract
Biomarkers can be used to aid the diagnosis of a disease (particularly early detection of occult tumours), to aid in the staging of disease, to predict outcome of disease, to act as a surrogate for clinical progression and to monitor responses to treatment. It is therefore important when referring to biomarkers to state exactly which of these indications is being sought. There is a real clinical need for biomarkers in all these stages, especially where patient stratification prior to treatment can considerably improve the outcome of clinical trials. Cancer, being a heterogeneous disease, is unlikely to respond to any one specific treatment and biomarkers that could tell us if the patient and their cancer was resistant to certain drugs would be very useful and, indeed, these are being sought. In an analogous way these are even more necessary with regards to vaccines, which would benefit greatly from patient stratification and early prediction of disease response [1].
Keywords: Biomarkers, cancer vaccines, cytokine profiles
Current Cancer Therapy Reviews
Title: Practical Aspects in the Use of Biomarkers for the Development of Cancer Vaccines
Volume: 4 Issue: 2
Author(s): Angus G. Dalgleish
Affiliation:
Keywords: Biomarkers, cancer vaccines, cytokine profiles
Abstract: Biomarkers can be used to aid the diagnosis of a disease (particularly early detection of occult tumours), to aid in the staging of disease, to predict outcome of disease, to act as a surrogate for clinical progression and to monitor responses to treatment. It is therefore important when referring to biomarkers to state exactly which of these indications is being sought. There is a real clinical need for biomarkers in all these stages, especially where patient stratification prior to treatment can considerably improve the outcome of clinical trials. Cancer, being a heterogeneous disease, is unlikely to respond to any one specific treatment and biomarkers that could tell us if the patient and their cancer was resistant to certain drugs would be very useful and, indeed, these are being sought. In an analogous way these are even more necessary with regards to vaccines, which would benefit greatly from patient stratification and early prediction of disease response [1].
Export Options
About this article
Cite this article as:
Dalgleish G. Angus, Practical Aspects in the Use of Biomarkers for the Development of Cancer Vaccines, Current Cancer Therapy Reviews 2008; 4 (2) . https://dx.doi.org/10.2174/157339408784310098
DOI https://dx.doi.org/10.2174/157339408784310098 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Polysaccharide Colloids as Smart Vehicles in Cancer Therapy
Current Pharmaceutical Design A Proteomic Analysis of Human Uterine Myoma
Current Protein & Peptide Science Design and Endpoints of Clinical and Translational Trials in Advanced Colorectal Cancer. A Proposal from GROUP Español Multidisciplinar en Cancer Digestivo (GEMCAD)
Reviews on Recent Clinical Trials Evaluation of Osteoporosis Risk Associated with Chronic Use of Morphine, Fentanyl and Tramadol in Adult Female Rats
Current Drug Safety Lipid Metabolism and Mitochondria: Cross Talk in Cancer
Current Drug Targets Promising Protective Effects of Chrysin in Cardiometabolic Diseases
Current Drug Targets Area, Age and Gender Dependence of the Nucleoside System in the Brain: a Review of Current Literature
Current Topics in Medicinal Chemistry IO Nation: The Rise of Immuno-Oncology
Current Pharmacogenomics and Personalized Medicine Fluorine-18 Labeled Amino Acids for Oncologic Imaging with Positron Emission Tomography
Current Topics in Medicinal Chemistry 1,3,4-Thiadiazole Based Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Nitrogen-Containing Heterocycles as Anticancer Agents: An Overview
Anti-Cancer Agents in Medicinal Chemistry Natural compound-derived epigenetic regulators targeting epigenetic readers, writers and erasers
Current Topics in Medicinal Chemistry Nano-Enabled Drug Delivery in Cancer Therapy: Literature Analysis Using the MeSH System
Pharmaceutical Nanotechnology Targeting the Folate Receptor: Improving Efficacy in Inorganic Medicinal Chemistry
Current Medicinal Chemistry Tumor Stroma Manipulation By MSC
Current Drug Targets Biotransformations of Prenylated Hop Flavonoids for Drug Discovery and Production
Current Drug Metabolism New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer
Current Pharmaceutical Design Human Cancer Cell Line Based Approach of 1,3,4-thiadiazole and its Fused Ring: A Comprehensive Review
Anti-Cancer Agents in Medicinal Chemistry Role of Chemokines and Their Receptors in Cancer
Current Pharmaceutical Design Methylaervine as Potential Lead Compound Against Cervical Carcinoma: Pharmacologic Mechanism Prediction based on Network Pharmacology
Current Computer-Aided Drug Design